Our GSEA results revealed that increased HS2ST1 expression activated mTORC1 signaling, E2F-dependent gene expression, G2M checkpoint and protein secretion in three cohorts of HCC patients. This evidence concerns the gene HS2ST1 and hepatocellular carcinoma.